Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 103 | 0.640 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2021 | 128 | 0.340 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 3022 | 0.340 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2019 | 487 | 0.280 |
Why?
|
| GTP-Binding Protein alpha Subunits | 2 | 2021 | 41 | 0.230 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2019 | 51 | 0.210 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2021 | 94 | 0.190 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2019 | 45 | 0.170 |
Why?
|
| Oncolytic Viruses | 1 | 2021 | 165 | 0.170 |
Why?
|
| Oncolytic Virotherapy | 1 | 2021 | 235 | 0.160 |
Why?
|
| Myeloid Cells | 1 | 2020 | 277 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2020 | 248 | 0.150 |
Why?
|
| GTP-Binding Proteins | 1 | 2019 | 347 | 0.150 |
Why?
|
| Second Messenger Systems | 1 | 2017 | 37 | 0.150 |
Why?
|
| Adenoviridae | 1 | 2021 | 1510 | 0.130 |
Why?
|
| Neoplasms | 1 | 2020 | 15915 | 0.110 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 1841 | 0.090 |
Why?
|
| HEK293 Cells | 3 | 2019 | 1470 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 1825 | 0.080 |
Why?
|
| Protein Binding | 3 | 2021 | 3528 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 3947 | 0.080 |
Why?
|
| Ligands | 2 | 2021 | 1057 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5248 | 0.050 |
Why?
|
| Single-Chain Antibodies | 1 | 2021 | 60 | 0.050 |
Why?
|
| Fenoterol | 1 | 2019 | 2 | 0.040 |
Why?
|
| Receptors, Vasopressin | 1 | 2019 | 25 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2019 | 73 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2021 | 267 | 0.040 |
Why?
|
| Isoproterenol | 1 | 2019 | 135 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2019 | 99 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2021 | 631 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 163 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2019 | 141 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2019 | 404 | 0.040 |
Why?
|
| Epinephrine | 1 | 2019 | 249 | 0.040 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2017 | 21 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2019 | 718 | 0.040 |
Why?
|
| Kinetics | 1 | 2019 | 2242 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2019 | 1501 | 0.030 |
Why?
|
| Binding Sites | 1 | 2019 | 2298 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 2035 | 0.030 |
Why?
|
| Humans | 6 | 2021 | 271884 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 1756 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 1075 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 1610 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3928 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 3072 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 5432 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2019 | 12222 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2021 | 2649 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 5330 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 6638 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 14875 | 0.020 |
Why?
|
| Animals | 2 | 2019 | 62807 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 36041 | 0.010 |
Why?
|
| Male | 1 | 2021 | 128957 | 0.010 |
Why?
|
| Female | 1 | 2021 | 149143 | 0.010 |
Why?
|